Add BrightSurf on Google Email

Genetic testing beneficial in critically ill adults

A study of 365 adults found nearly one in four had a genetic condition causing their ICU admission, which was unknown to nearly half of those patients and their doctors. The researchers recommend offering genetic testing to all adults admitted to the ICU to improve care and reduce health disparities.

SourceUniversity of Pennsylvania·JournalAmerican Journal of Human Genetics·TypeData/statistical analysis·DateJul 15, 2025

New gene therapy delivery device could let hospitals create personalized nanomedicines on-demand

A new gene therapy delivery device called NANOSPRESSO could revolutionize how hospitals treat rare diseases by allowing them to create personalized nanomedicines in-house. This democratized approach to precision medicine could boost access to low-cost bespoke gene and RNA therapies, especially in low-resource settings.

SourceFrontiers·JournalFrontiers in Science·TypeSystematic review·DateJun 26, 2025

Olympians' hearts in focus: groundbreaking study reveals elite rowers' surprising AFib risk

A new study involving 121 former elite rowers from Australia found that one in five develops atrial fibrillation, a condition that can lead to stroke and heart failure. The researchers identified genetic and clinical tools that enable early preventive strategies, highlighting the paradox that AFib is more common among fit athletes.

SourceVictor Chang Cardiac Research Institute·JournalEuropean Heart Journal·TypeObservational study·DateJun 25, 2025

An international study validates the efficacy of a drug in adults with neurofibromatosis type 1

A phase 3 trial demonstrated the efficacy of selumetinib in reducing tumor size and alleviating pain in adults with neurofibromatosis type 1. The treatment was found to be effective in patients who received it from day one, as well as those who started it later, with significant reductions in tumor size and pain reported.

SourceGermans Trias i Pujol Research Institute·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJun 25, 2025

New hope for patients with Werner syndrome

Researchers have discovered that nicotinamide riboside supplementation significantly improves NAD+ levels, reducing arterial stiffness, skin ulcer area, and kidney dysfunction. This breakthrough offers new hope for patients with Werner syndrome who lack effective treatment options.

SourceChiba University·JournalAging Cell·TypeExperimental study·DateJun 5, 2025

International study: Asthma drug could help to treat a rare neurological disorder

A new study published by Martin-Luther-Universität Halle-Wittenberg found that theophylline significantly improved symptoms and quality of life for patients with ADCY5-related dyskinesia. The treatment yielded impressive results, including reduced muscle twitches, improved gait, and better psychosocial well-being.

SourceMartin-Luther-Universität Halle-Wittenberg·JournalMovement Disorders·TypeExperimental study·DateJun 3, 2025

New clues to autism: epigenetic study identifies RABGGTB as a novel candidate gene

A recent epigenetic study identified RABGGTB as a promising biomarker for autism spectrum disorder, revealing extensive DNA methylation abnormalities in key brain regions. The findings suggest that studying this gene could unlock new doors to understanding ASD and lead to future diagnostic breakthroughs.

SourceUniversity of Fukui·JournalPsychiatry and Clinical Neurosciences·TypeExperimental study·DateMay 21, 2025

Prader-Willi syndrome reveals unique link between genetics and psychiatric disorders

Researchers have synthesized cutting-edge findings on Prader-Willi syndrome, revealing its unique link to autism spectrum disorder and psychotic spectrum disorders. The condition's distinct genetic subtypes correlate with specific psychiatric outcomes, offering critical insights into the interplay between genetics and psychiatric vulne...

SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateMay 20, 2025

Study: NIPT identifies twice as many down syndrome cases as STSS

A novel study analyzing the cost-effectiveness of different Down syndrome screening strategies confirms that non-invasive prenatal testing (NIPT) significantly outperforms second-trimester serum screening (STSS). NIPT identifies twice as many DS cases as STSS, offering a more reliable option with lower incremental costs.

SourceBGI Genomics·JournalFrontiers in Public Health·DateMay 16, 2025

Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment

A team of researchers has successfully treated an infant with a life-threatening, incurable genetic disease using personalized gene editing therapy. The infant, who was diagnosed shortly after birth, showed positive responses to the treatment and improved symptoms over time.

SourceNIH/Office of the Director·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMay 15, 2025

New gene linked to severe cases of Fanconi anemia

Researchers have identified a new gene, FANCX, associated with an aggressive form of Fanconi anemia. Mutations in this gene lead to severe forms of the disease, including miscarriages and early death. The discovery could help identify carriers who can prevent Fanconi anemia in future pregnancies through IVF screening.

SourceRockefeller University·JournalJournal of Clinical Investigation·DateMay 9, 2025

Substance use accelerates brain aging through distinct molecular pathways, groundbreaking study reveals

Researchers identified unique biological mechanisms that cause premature aging in the brains of individuals with alcohol, opioid, and stimulant use disorders. Different substances appear to hijack the brain's natural aging rhythm through distinct molecular mechanisms, though some pathways are shared across different substance types.

SourceGenomic Press·JournalGenomic Psychiatry·TypeExperimental study·DateApr 29, 2025

Israeli breakthrough identifies key gene in common heart disease, unlocking life-saving diagnostic potential

A pioneering Israeli study identifies TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM), which could transform genetic screening and treatment protocols. The findings provide compelling evidence for the gene’s role in both causing and increasing susceptibility to HCM.

SourceClalit Research Institute·JournalCirculation Genomic and Precision Medicine·TypeData/statistical analysis·DateApr 23, 2025

Retinal clues to mental health

A recent study by the University of Zurich examined the connection between retinal nerve connections and schizophrenia. The researchers found that individuals with a higher genetic risk for schizophrenia tend to have thinner retinas, which can be detected using non-invasive retinal measurements.

SourceUniversity of Zurich·JournalNature Mental Health·TypeExperimental study·DateApr 22, 2025

Landmark study identifies new genetic cause of neurodevelopmental disorders, bringing long-awaited answers to families

Researchers at Mount Sinai School of Medicine have identified a new genetic cause of neurodevelopmental disorders (NDDs), including mutations in the previously overlooked non-coding gene RNU2-2. The discovery offers hope to potentially thousands of families worldwide, providing closure and support for those affected by these conditions.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Genetics·TypeExperimental study·DateApr 10, 2025

New study reveals the curative potential of genome editing approach for genetic deafness

A new gene therapy developed by researchers from Juntendo University uses AAV to deliver genome editing tools to inner ear cells, repairing a dominant-negative mutation that causes syndromic hearing loss. The approach has shown high efficiency and specificity in treating hereditary hearing loss.

SourceJuntendo University Research Promotion Center·JournalJCI Insight·TypeExperimental study·DateMar 27, 2025

Dr. Vikaas Sohal of The University of California, San Francisco receives a $130,000 SynGAP Research Fund (SRF) grant to explore therapeutic strategies for reversing cognitive deficits in SYNGAP1-related disorders

Dr. Vikaas Sohal's research focuses on cognitive flexibility and prefrontal gamma oscillations to improve cognitive function in individuals with SYNGAP1-related disorders. The grant aims to confirm findings in Syngap1 mutant mice and explore new therapeutic strategies.

New study sheds light on how bacteria ‘vaccinate’ themselves with genetic material from dormant viruses

Scientists at Johns Hopkins Medicine discovered how bacteria protect themselves from certain phage invaders by seizing genetic material from weakened, dormant phages and forming a biological 'memory' that their offspring inherit. This process allows the bacteria to recognize and fight off similar viruses in the future.

SourceJohns Hopkins Medicine·JournalCell Host & Microbe·DateMar 21, 2025

Dr. Julia Dallman awarded SynGAP Research Fund (SRF) grant for SYNGAP1 research targeting gastro-intestinal treatment development

Dr. Julia Dallman has been awarded a $65,000 grant by the SynGAP Research Fund to screen pro-GI motility compounds for reducing gut transit time in her zebrafish SYNGAP1 model. The project aims to identify therapeutic options that can alleviate severe GI symptoms and improve quality of life for individuals with SYNGAP1-related disorders.

Dr. Megan Abbott and the University of Colorado awarded $450,000 establishing a Clinical Research Center of Excellence that will also serve as a second site for SYNGAP1 ProMMiS

A new Clinical Research Center of Excellence will improve care for individuals with SYNGAP1-related disorders and expand the Natural History Study to include Prospective Multidisciplinary Multisite Study. The center, established at Children's Hospital Colorado, aims to accelerate research and provide specialized care.

Don’t bin your blood

Australian Red Cross Lifeblood researchers surveyed over 4,000 people with haemochromatosis and found that their blood and plasma can be used to save lives. The study highlights the potential for these donors to increase blood supplies globally, particularly in countries accepting plasma donations from individuals with this condition.

SourceAustralian Red Cross Lifeblood·JournalTransfusion·TypeSurvey·DateFeb 18, 2025